gman, read the post I put up prior to yours #9310

gman, read the post I put up prior to yours #9310

I found the poster artificialselecter and his post.

Once again, this is what he wrote:


artificialselecter Wednesday, 03/18/20 11:29:47 AM
Re: mfdesigner post# 60213 0
Post #
60231
of 62809
https://www.pharmatechsolutions.co/assets/ins...ro!_PP.pdf

Here is the link. This tech looks great, nice idea to use monoclonal Ab for a specific viral envelope marker. Read current biophysics/bioelectronics/materials science journals and you’ll see that many biosensor technologies have used a similar design. Concept has been validated in these additional studies.

I agree it would be refreshing to see false positive and false negative rates. But from what I’ve read, there can be a relatively large margin of error and FDA can still deem the test effective. These types of diagnostic tests have less stringent efficacy criteria than molecular amplification-based diagnostics.

Glty

Read More: https://investorshangout.com/post/view?id=571...z6HXWI1fP1

and


artificialselecter Wednesday, 03/18/20 10:53:38 AM
Re: mfdesigner post# 60182 0
Post #
60185
of 62822
It’s impedance, impedance increases when more viral protein is bound to the antibody fixed to the substrate. Can change which virus is detected by swapping the fixed antibody. Read the PowerPoint presentation!

It appears AlwaysSum1ElsesFault is telling us GenViro! is a great idea!